[go: up one dir, main page]

CN108042488A - A kind of method for reducing micro emulsion dosage of surfactant - Google Patents

A kind of method for reducing micro emulsion dosage of surfactant Download PDF

Info

Publication number
CN108042488A
CN108042488A CN201710734760.9A CN201710734760A CN108042488A CN 108042488 A CN108042488 A CN 108042488A CN 201710734760 A CN201710734760 A CN 201710734760A CN 108042488 A CN108042488 A CN 108042488A
Authority
CN
China
Prior art keywords
surfactant
microemulsion
oil
micro emulsion
area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710734760.9A
Other languages
Chinese (zh)
Inventor
田青平
张淑秋
王雨
景盼盼
谭笑
谢茵
郝嘉敏
杨冬娟
乔莉婕
曹瑞
卫晶晶
侯宏保
李鹏艳
李宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi Medical University
Original Assignee
Shanxi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi Medical University filed Critical Shanxi Medical University
Priority to CN201710734760.9A priority Critical patent/CN108042488A/en
Publication of CN108042488A publication Critical patent/CN108042488A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/068Microemulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)

Abstract

The present invention provides a kind of method for reducing dosage of surfactant in micro emulsion.Using the common oily and another grease class material mixing for preparing micro emulsion as oil phase, under the action of surfactant, stir, micro emulsion can be formed by being titrated dropwise with water.When mixing such as olive oil with Vitamin E succinate as oil phase, the micro emulsion region of olive oil increased dramatically, and can form the ratio between oil and surfactant of micro emulsion region(O/S)More than 5/5 can be increased to by the 1/9 of simple olive oil, significantly reduce the dosage of surfactant and without the participation of cosurfactant short chain alcohol.The invention can be such that micro emulsion is more widely applied in terms of industrial or agricultural and medicine as carrier, more can provide foundation for the theoretical in-depth of micro emulsion solubilising and supplement.

Description

一种降低微乳表面活性剂用量的方法A method for reducing the amount of microemulsion surfactant

技术领域technical field

本发明涉及一种微乳的制备方法,特别是一种无需助表面活性剂、极大地降低表面活性剂用量的微乳的制备方法。The invention relates to a preparation method of microemulsion, in particular to a preparation method of microemulsion without co-surfactant and greatly reducing the amount of surfactant.

背景技术Background technique

微乳通常由表面活性剂(S)、助表面活性剂(C)、油(O)和水四种成分组成。常用的油有十四酸异丙酯、硬脂酸甘油酯、乙酸乙酯、油酸、薄荷油以及各种植物油如豆油、橄榄油和玉米油等。用这些油制备微乳时S和C的用量很大,仅当油与表面活性剂的质量比(O/SC)低于2/8时,才有可能形成微乳,植物油的微乳区域则更小,O/SC低于0.5/9.5。S与C用量大,限制了微乳的应用,尤其是作为药物及化妆品载体的应用。Microemulsions are usually composed of four components: surfactant (S), co-surfactant (C), oil (O) and water. Commonly used oils are isopropyl myristate, glyceryl stearate, ethyl acetate, oleic acid, peppermint oil, and various vegetable oils such as soybean oil, olive oil, and corn oil. When using these oils to prepare microemulsions, the amount of S and C is very large. Only when the mass ratio of oil to surfactant (O/SC) is lower than 2/8, is it possible to form microemulsions, and the microemulsion area of vegetable oils is Smaller, O/SC lower than 0.5/9.5. The large amount of S and C limits the application of microemulsion, especially as the application of drug and cosmetic carrier.

发明内容Contents of the invention

本发明为了降低微乳中表面活性剂的使用量,使之更安全有效地应用为药物、化妆品等的载体,特提供一种降低微乳表面活性剂用量的方法。In order to reduce the amount of surfactant used in the microemulsion and make it more safely and effectively used as a carrier for medicines and cosmetics, the present invention provides a method for reducing the amount of surfactant used in the microemulsion.

一种降低微乳中表面活性剂用量的方法,将微乳中的油与另一种油酯类物质混合作为油相,在表面活性剂的作用下,搅拌,用水逐滴滴定即可形成。A method for reducing the amount of surfactant in the microemulsion. The oil in the microemulsion is mixed with another oily ester as the oil phase. Under the action of the surfactant, it is stirred and titrated with water drop by drop.

本发明避免了常规微乳制备中大量的助表面活性剂短链醇的使用,也即微乳的形成无需助表面活性剂的参与。The present invention avoids the use of a large amount of co-surfactant short-chain alcohols in conventional microemulsion preparation, that is, the formation of microemulsion does not require the participation of co-surfactant.

本发明所述降低微乳中表面活性剂用量的方法,相应地,也就是说提高油相物质在微乳中载入量的方法是加入另一种油酯类物质,两种油脂类物质双方相互增溶,对其性质和两者的比例无特别限制,也即油脂类物质的性质和复配比例无特别限制。The method for reducing the amount of surfactant in the microemulsion according to the present invention, correspondingly, that is to say, the method for improving the load of the oil phase substance in the microemulsion is to add another kind of oily ester substance, both of the two kinds of oily substances Mutual solubilization, there are no special restrictions on its properties and the ratio of the two, that is, there are no special restrictions on the properties and compounding ratio of oily substances.

本发明中,表面活性剂的选择只与HLB值(表面活性剂的亲水亲油平衡值)有关而与种类无关;安全考虑优选非离子型表面活性剂,可以是一种或多种的复配。In the present invention, the choice of surfactant is only related to the HLB value (hydrophilic-lipophilic balance value of the surfactant) and has nothing to do with the type; safety considerations are preferably non-ionic surfactants, which can be one or more complex match.

本发明的优点是:The advantages of the present invention are:

(1)该发明制备简单,无需分散设备和条件,只需搅拌即可自发形成。(1) The preparation of the invention is simple, no dispersing equipment and conditions are required, and it can be formed spontaneously only by stirring.

(2)该发明极大地提高了微乳区域,即在表面活性剂含量低、油相载入量高的情况下,可较大范围调节水的含量,从而制备油包水型、水包油型或双连续型各种类型的微乳。(2) The invention greatly improves the microemulsion area, that is, in the case of low surfactant content and high oil phase loading, the water content can be adjusted in a wide range, thereby preparing water-in-oil and oil-in-water Various types of microemulsions of type or bicontinuous type.

(3)该发明可极大地提高微乳的增溶作用,无论大分子、小分子,油溶性物质还是脂溶性物质均可较大量地根据其溶解特性增溶于微乳的不同部位,如油相、水相或微乳粒子表面。(3) This invention can greatly improve the solubilization of microemulsions, regardless of macromolecules, small molecules, oil-soluble substances or fat-soluble substances can be solubilized in different parts of microemulsions according to their solubility characteristics, such as oil phase, aqueous phase or the surface of microemulsion particles.

附图说明Description of drawings

图1 实施例1所述的三元相图;橄榄油/维生素E琥珀酸酯 =6:1 RH40:Span80=3:1。Fig. 1 Ternary phase diagram described in Example 1; olive oil/vitamin E succinate=6:1 RH40:Span80=3:1.

图2实施例2所述的三元相图;橄榄油/维生素E琥珀酸酯 =5:1 RH40:Span80=5:1。The ternary phase diagram described in Fig. 2 embodiment 2; olive oil/vitamin E succinate=5:1 RH40:Span80=5:1.

图3 实施例3所述的三元相图;橄榄油/维生素E琥珀酸酯 =4:1 RH40:Span80=3:1。Fig. 3 The ternary phase diagram described in Example 3; olive oil/vitamin E succinate=4:1 RH40:Span80=3:1.

图4实施例4所述的三元相图;橄榄油/维生素E琥珀酸酯 =3:1 RH40:Span80=4:1。The ternary phase diagram described in Fig. 4 Example 4; olive oil/vitamin E succinate=3:1 RH40:Span80=4:1.

图5实施例5所述的三元相图;橄榄油/维生素E琥珀酸酯 =2:1 RH40:Span80=4:1。The ternary phase diagram described in Fig. 5 Example 5; olive oil/vitamin E succinate=2:1 RH40:Span80=4:1.

图6实施例6所述的三元相图;橄榄油/硅酸四乙酯=5:1 Tween80:Span80=3:1。The ternary phase diagram described in Fig. 6 Example 6; olive oil/tetraethyl silicate=5:1 Tween80:Span80=3:1.

图7实施例7所述的三元相图;橄榄油/乙酸乙脂 =6:1 Tween80:Span80=4:1The ternary phase diagram described in Fig. 7 embodiment 7; Olive oil/ethyl acetate=6:1 Tween80:Span80=4:1

图8实施例8所述的三元相图;十四酸异丙脂/维生素E琥珀酸酯 =4:1 RH40:Span80=4:1。The ternary phase diagram described in Fig. 8 Example 8; isopropyl myristate/vitamin E succinate=4:1 RH40:Span80=4:1.

图9实施例9所述的三元相图;十四酸异丙脂/硅酸四乙酯质量比为4:1, Tween80与Span80质量比为3:1。Figure 9 is the ternary phase diagram described in Example 9; the mass ratio of isopropyl myristate/tetraethyl silicate is 4:1, and the mass ratio of Tween80 and Span80 is 3:1.

图10表征例中样品1的粒径分布图。Fig. 10 represents the particle size distribution diagram of sample 1 in the examples.

图11表征例中样品2的粒径分布图。Fig. 11 represents the particle size distribution diagram of sample 2 in the examples.

图12表征例中样品3的粒径分布图。Fig. 12 represents a particle size distribution diagram of sample 3 in Examples.

图13在TEM-100Ⅻ型透射电子显微镜下观察样品1的微观形态;左侧图为稀释50倍,放大倍数15K;右侧图为稀释50倍,放大倍数60k。Fig. 13 The microscopic morphology of sample 1 observed under a TEM-100XII transmission electron microscope; the picture on the left shows a 50-fold dilution with a magnification of 15K; the picture on the right shows a 50-fold dilution with a magnification of 60K.

图14水性面膜的电镜图。The electron micrograph of Fig. 14 water-based facial mask.

具体实施方式Detailed ways

实施例1Example 1

将橄榄油与维生素E琥珀酸酯按质量比6:1混合,得油相储备液。将聚氧乙烯氢化蓖麻油(RH40)与Span80按质量比3:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图1为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and vitamin E succinate in a mass ratio of 6:1 to obtain an oil phase stock solution. Mix polyoxyethylene hydrogenated castor oil (RH40) and Span80 at a mass ratio of 3:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 1 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例2Example 2

将橄榄油与维生素E琥珀酸酯按质量比5:1混合,得油相储备液。将RH40与Span80按质量比5:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图2为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and vitamin E succinate in a mass ratio of 5:1 to obtain an oil phase stock solution. Mix RH40 and Span80 at a mass ratio of 5:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 2 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例3Example 3

将橄榄油与维生素E琥珀酸酯按质量比4:1混合,得油相储备液。将RH40与Span80按质量比3:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图3为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and vitamin E succinate in a mass ratio of 4:1 to obtain an oil phase stock solution. Mix RH40 and Span80 at a mass ratio of 3:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 3 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例4Example 4

将橄榄油与维生素E琥珀酸酯质量比3:1混合,得油相储备液。将RH40与Span80按质量比4:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图4为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and vitamin E succinate in a mass ratio of 3:1 to obtain an oil phase stock solution. Mix RH40 and Span80 at a mass ratio of 4:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 4 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例5Example 5

将橄榄油与维生素E琥珀酸酯质量比2:1混合,得油相储备液。将RH40与Span80按质量比4:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图5为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and vitamin E succinate in a mass ratio of 2:1 to obtain an oil phase stock solution. Mix RH40 and Span80 at a mass ratio of 4:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 5 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例6Example 6

将橄榄油与硅酸四乙酯按质量比5:1混合,得油相储备液。将Tween80与Span80按质量比3:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图6为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and tetraethyl silicate at a mass ratio of 5:1 to obtain an oil phase stock solution. Mix Tween80 and Span80 at a mass ratio of 3:1 to obtain a surfactant stock solution. Mix the oil phase and surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 6 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例7Example 7

将橄榄油与乙酸乙脂按质量比6:1混合,得油相储备液。将Tween80与Span80按质量比4:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图7为该配比条件下的相图,黑色区域即为微乳区。Mix olive oil and ethyl acetate in a mass ratio of 6:1 to obtain an oil phase stock solution. Mix Tween80 and Span80 at a mass ratio of 4:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 7 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例8Example 8

将十四酸异丙脂与维生素E琥珀酸酯按质量比4:1混合,得油相储备液。将RH40与Span80按质量比4:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图8为该配比条件下的相图,黑色区域即为微乳区。Mix isopropyl myristate and vitamin E succinate in a mass ratio of 4:1 to obtain an oil phase stock solution. Mix RH40 and Span80 at a mass ratio of 4:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 8 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

实施例9Example 9

将十四酸异丙脂与硅酸四乙酯按质量比4:1混合,得油相储备液。将Tween80与Span80按质量比3:1混合,得表面活性剂储备液。将油相与表面活性剂按比例混合成10g的混合液,搅拌均匀,O/S分别为0.5/9.5、1/9、1.5/8.5、2/8、……、9/1、9.5/0.5。对每个O/S比例的混合液用蒸馏水滴定,记录由清变浊或由浊变清时蒸馏水的消耗量得微乳区域的边界点。以油、表面活性剂、蒸馏水的百分含量为变量,绘制三元相图,目测为透明或略带兰色晕光的半透明区域即为微乳区。图9为该配比条件下的相图,黑色区域即为微乳区。Mix isopropyl myristate and tetraethyl silicate at a mass ratio of 4:1 to obtain an oil phase stock solution. Mix Tween80 and Span80 at a mass ratio of 3:1 to obtain a surfactant stock solution. Mix the oil phase and the surfactant in proportion to form a 10g mixture, stir evenly, and the O/S are 0.5/9.5, 1/9, 1.5/8.5, 2/8, ..., 9/1, 9.5/0.5 . Titrate the mixed solution of each O/S ratio with distilled water, and record the consumption of distilled water when changing from clear to turbid or from turbid to clear to obtain the boundary point of the microemulsion area. With the percentage of oil, surfactant, and distilled water as variables, the ternary phase diagram is drawn, and the translucent area that is transparent or slightly blue halo is the microemulsion area. Figure 9 is the phase diagram under the condition of this ratio, and the black area is the microemulsion area.

本发明人以橄榄油微乳为载体进行化妆品的开发,通过单因素考察发现提高橄榄油微乳区域的成分为维生素E琥珀酸酯,微乳中其它成分如助表面活性剂短链醇、促渗剂等对微乳的形成均无影响,S的选择只与HLB有关而与S的类型无关。在此基础上,发明人又选择其它几种油脂类物质两两复配,进一步验证了两种油脂类物质复配后双方相互增溶,可极大地提高微乳区域的客观事实。The present inventor uses olive oil microemulsion as a carrier to develop cosmetics. Through single factor investigation, it is found that the component that improves the olive oil microemulsion area is vitamin E succinate, and other components in the microemulsion such as cosurfactant short chain The osmotic agents have no effect on the formation of microemulsions, and the choice of S is only related to HLB and has nothing to do with the type of S. On this basis, the inventor selected several other oils and fats to compound in pairs, and further verified that after the two oils and fats are compounded, both sides can solubilize each other, which can greatly improve the objective fact of the microemulsion area.

微乳形成的机理有多种,被普遍接受的是混合膜理论和瞬时负界面张力理论,最不被普遍认可的是增溶理论。本发明为增溶理论的接受和深化提供了很好的实验支持,也为微乳载体的广泛应用提供了物质基础。There are many mechanisms for the formation of microemulsions, the mixed film theory and the instantaneous negative interfacial tension theory are generally accepted, and the solubilization theory is the least generally accepted. The invention provides good experimental support for the acceptance and deepening of the solubilization theory, and also provides a material basis for the wide application of the microemulsion carrier.

表征例:Representation example:

选取三个微乳处方,分别测定其平均粒径与多聚指数PDI,结果如表1及图10,11,12所示。三个微乳的组成分别为:样品1,橄榄油与维生素E琥珀酸酯质量比6:1,RH40与Span80质量比3:1,O/S为4.5 / 5.5;样品2,RH40与Span80质量比4:1,O/S为4.6 / 5.4;样品3,RH40与Span80质量比5:1,O/S为4.8 / 5.2;三个样品均制备20g,其水含量均为80%。Three microemulsion formulations were selected, and their average particle size and poly index PDI were measured respectively. The results are shown in Table 1 and Figures 10, 11, and 12. The compositions of the three microemulsions are: sample 1, mass ratio of olive oil to vitamin E succinate 6:1, mass ratio of RH40 to Span80 3:1, O/S 4.5 / 5.5; sample 2, mass ratio of RH40 to Span80 Ratio 4:1, O/S is 4.6 / 5.4; sample 3, mass ratio of RH40 and Span80 is 5:1, O/S is 4.8 / 5.2; three samples are prepared in 20g, and their water content is 80%.

可见,三个样品的粒径均在微乳小于100nm的范围内,粒径分布均匀,多聚指数均小于0.2。It can be seen that the particle sizes of the three samples are all in the range of microemulsions less than 100nm, the particle size distribution is uniform, and the poly index is all less than 0.2.

采用负染色法制备样品,在TEM-100Ⅻ型透射电子显微镜下观察样品1的微观形态,结果如图13,左侧图为稀释50倍,放大倍数15K;右侧图为稀释50倍,放大倍数60k。可见,微乳粒径在纳米级范围,粒子呈球型分布,形态圆整。The sample was prepared by negative staining method, and the microscopic morphology of sample 1 was observed under a TEM-100XII transmission electron microscope. The results are shown in Figure 13. The left picture shows a 50-fold dilution with a magnification of 15K; the right picture shows a 50-fold dilution with a magnification 60k. It can be seen that the particle size of the microemulsion is in the nanometer range, the particles are spherically distributed, and the shape is round.

应用实例:Applications:

按照橄榄油2.46%、维生素E琥珀酸脂0.41%、RH40为2.80%、Span80为0.56%、余者为去离子水的配比先制备空白微乳。然后加入透明质酸 0.3%、海藻酸钠0.1%、尿囊素0.1%、胶原蛋白0.5%、丙二醇3%、熊果苷1%、甘油5%、尼泊金甲酯钠0.025% 、尼泊金丙酯钠0.25%、薰衣草精油数滴,拟制备成一种水性面膜。A blank microemulsion was first prepared according to the ratio of olive oil 2.46%, vitamin E succinate 0.41%, RH40 2.80%, Span80 0.56%, and the rest deionized water. Then add hyaluronic acid 0.3%, sodium alginate 0.1%, allantoin 0.1%, collagen 0.5%, propylene glycol 3%, arbutin 1%, glycerin 5%, sodium methylparaben 0.025%, paraben Sodium auryl propylate 0.25%, a few drops of lavender essential oil, to be prepared into a water-based facial mask.

经测定其粒径为59.5nm、PDI指数为0.27,黏度为140.95±0.35mPa·s,微观形态如图14。可见,无论大分子还是小分子,水溶性的还是脂溶性的物质均可载入微乳,且载入大量物质后仍符合微乳的特征。Its particle size was determined to be 59.5nm, its PDI index was 0.27, and its viscosity was 140.95±0.35mPa·s. The microscopic morphology is shown in Figure 14. It can be seen that regardless of macromolecules or small molecules, water-soluble or fat-soluble substances can be loaded into microemulsions, and the characteristics of microemulsions are still met after loading a large amount of substances.

Claims (4)

1.一种降低微乳中表面活性剂用量的方法,其特征在于将制备微乳的常用油与另一种油酯类物质混合作为油相,在表面活性剂的作用下,搅拌,用水逐滴滴定即可形成。1. A method for reducing the amount of surfactant in the microemulsion is characterized in that the common oil used to prepare the microemulsion is mixed with another oily ester substance as the oil phase, under the effect of the surfactant, stirring, and water gradually Droplets are titrated to form. 2.根据权利要求1所述的一种降低微乳中表面活性剂用量的方法,其特征在于:微乳的形成无需助表面活性剂即短链醇的参与。2. a kind of method reducing surfactant consumption in microemulsion according to claim 1 is characterized in that: the formation of microemulsion does not need the participation of cosurfactant i.e. short-chain alcohol. 3.根据权利要求1所述的一种降低微乳中表面活性剂用量的方法,其特征在于:降低微乳中表面活性剂用量的方法,相应地,也就是说提高油相物质在微乳中载入量的方法是加入另一种油酯类物质,两种油脂类物质双方相互增溶,对其性质和两者的比例无特别限制。3. a kind of method for reducing surfactant consumption in microemulsion according to claim 1, is characterized in that: reduce the method for surfactant consumption in microemulsion, correspondingly, that is to say improves oil phase substance in microemulsion The medium loading method is to add another oil and ester substance, and the two oil and fat substances solubilize each other, and there is no special limitation on their properties and the ratio of the two. 4.根据权利要求1所述的一种降低微乳中表面活性剂用量的方法,其特征在于:表面活性剂对微乳区域的影响主要与其HLB值有关,而与种类无关;安全考虑采用非离子型表面活性剂,可以是一种或多种的复配。4. a kind of method reducing surfactant consumption in microemulsion according to claim 1 is characterized in that: surfactant is mainly relevant to its HLB value to the influence of microemulsion area, and has nothing to do with kind; Ionic surfactants can be one or more compounds.
CN201710734760.9A 2017-08-24 2017-08-24 A kind of method for reducing micro emulsion dosage of surfactant Pending CN108042488A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710734760.9A CN108042488A (en) 2017-08-24 2017-08-24 A kind of method for reducing micro emulsion dosage of surfactant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710734760.9A CN108042488A (en) 2017-08-24 2017-08-24 A kind of method for reducing micro emulsion dosage of surfactant

Publications (1)

Publication Number Publication Date
CN108042488A true CN108042488A (en) 2018-05-18

Family

ID=62119319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710734760.9A Pending CN108042488A (en) 2017-08-24 2017-08-24 A kind of method for reducing micro emulsion dosage of surfactant

Country Status (1)

Country Link
CN (1) CN108042488A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109010117A (en) * 2018-07-10 2018-12-18 山西医科大学 A kind of micro emulsion gel lip care gel and preparation method thereof with moist moisture-keeping function

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1612697A (en) * 2002-01-31 2005-05-04 阿彻-丹尼尔斯-米德兰公司 Isotropic transparent compositions containing fat soluble vitamin
CN1717219A (en) * 2002-11-29 2006-01-04 韩美药品株式会社 Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
CN101028240A (en) * 2007-03-29 2007-09-05 中国科学院上海药物研究所 Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method
CN102166233A (en) * 2011-04-06 2011-08-31 西北农林科技大学 Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1612697A (en) * 2002-01-31 2005-05-04 阿彻-丹尼尔斯-米德兰公司 Isotropic transparent compositions containing fat soluble vitamin
CN1717219A (en) * 2002-11-29 2006-01-04 韩美药品株式会社 Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
CN101028240A (en) * 2007-03-29 2007-09-05 中国科学院上海药物研究所 Micro-emulsion/submicro-emulsion in-situ gel preparation for eyes and its making method
CN102166233A (en) * 2011-04-06 2011-08-31 西北农林科技大学 Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
范薇: "罗红霉素自乳化制剂的制备及体外评价", 《中国医药指南》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109010117A (en) * 2018-07-10 2018-12-18 山西医科大学 A kind of micro emulsion gel lip care gel and preparation method thereof with moist moisture-keeping function
CN109010117B (en) * 2018-07-10 2021-05-25 山西医科大学 Micro-emulsion gel lip-protecting gel with moisturizing and moisturizing effects and preparation method thereof

Similar Documents

Publication Publication Date Title
Yilmaz et al. Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides
KR101363757B1 (en) Double layered capsule for cosmetics and method of manufacturing the same
Choi et al. Encapsulation of a bioactive peptide in a formulation of W1/O/W2-type double emulsions: Formation and stability
CN108451787B (en) Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof
JP2016539161A (en) Lipid microcapsules, preferably comprising lipophilic active substances, and compositions containing them, methods for their production and their use in dermatology and cosmetics
CN102821756B (en) Oil-in-water type nano-emulsion composition and method for preparing same
CN111417376B (en) Transparent cosmetic composition
Yan et al. Preparation of biodiesel oil-in-water nanoemulsions by mixed surfactants for bifenthrin formulation
Zainol et al. Development and characterization of cinnamon leaf oil nanocream for topical application
CN104921005A (en) Garlic oil nanometer-scale microemulsion liquid and preparation method thereof
JP2005193134A (en) One-phase microemulsion composition and its manufacturing method
Qi et al. Formulation and stability study of vitamin E microemulsion with green surfactant
JP2004520408A (en) Multi-layered emulsion for stabilizing skin useful substances and base for skin external preparation for treating a wide range of skin diseases using the same
JP2012206948A (en) Liposome composition, cosmetic and skin external preparation using the same, and method for producing the same
CN108042488A (en) A kind of method for reducing micro emulsion dosage of surfactant
CN110101659A (en) A kind of phillygenol is from micro emulsion and preparation method thereof
KR20030049558A (en) Cosmetic products which have lightening effect using water in oil in water(W/O/W) multiple liposome system with stabilized arbutin and their manufacturing methods
KR100570497B1 (en) Anti-wrinkle cosmetic composition comprising pure retinol encapsulated in a nano-sized multi-liquid crystal film and a method of manufacturing the same
CN115844738B (en) Oil-in-water microemulsion system of oil-soluble active ingredients and preparation method thereof
KR100501728B1 (en) Cosmetic composition having the capsule structure of multiple-liquid crystalline membrane with nano size and manufacturing method thereof
CN114452227B (en) Method for preparing alcohol-in-oil-in-water multiple pickering emulsion by anti-solvent recrystallization method
CN101502478B (en) Transparent nanoemulsion based on non-ionic amphiphilic surfactant and use thereof
JP6242422B2 (en) Cosmetic raw material manufacturing method
BRPI1100513A2 (en) development of polymeric nanoparticles by in situ polymerization from phase-investing nanoemulsions
TWI839286B (en) Rhodiola rosea nanoemulsion and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180518

RJ01 Rejection of invention patent application after publication